Concept information
Preferred term
Neopterin
Type
-
mesh:Descriptor
Definition
- A pteridine derivative present in body fluids; elevated levels result from immune system activation, malignant disease, allograft rejection, and viral infections. (From Stedman, 26th ed) Neopterin also serves as a precursor in the biosynthesis of biopterin.
Broader concept
Entry terms
- 10162-32-0 ((threo-D)-isomer)
- 2009-64-5 ((erythro-D)-isomer)
- 2277-42-1 ((threo-L)-isomer)
- 2277-43-2 ((erythro-L)-isomer)
- 2-Amino-6-(1,2,3-trihydroxypropyl)-4(3H)-pteridinone
- 670-65-5
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- biosynthesis (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- deficiency (Qualifier)
- economics (Qualifier)
- genetics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- physiology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
In other languages
-
French
-
10162-32-0 ((threo-D)-isomer)
-
2009-64-5 ((erythro-D)-isomer)
-
2277-42-1 ((threo-L)-isomer)
-
2277-43-2 ((erythro-L)-isomer)
-
670-65-5
URI
http://data.loterre.fr/ark:/67375/JVR-G9FBWQ47-D
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}